The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cost-effectiveness analysis per life-year gained based on predictors of response for first-line metastatic colorectal cancer therapy in Spain.
Cristobal Belda-Iniesta
No relevant relationships to disclose
Victor Moreno
No relevant relationships to disclose
Brezo Martinez-Amores
No relevant relationships to disclose
Jorge Barriuso
No relevant relationships to disclose
Laura Mezquita
No relevant relationships to disclose
Inmaculada Ibañez de Cáceres
No relevant relationships to disclose
Angel Ayuso Sacido
No relevant relationships to disclose
Jose Maria Peña
No relevant relationships to disclose
Rosario Perona
No relevant relationships to disclose